Company: AIZ
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001267238-25-000026
Chunk: 4

Company: ASSURANT, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 1A
Chunk 4
---
Item 1A. Risk Factors 

Certain factors may have a material adverse effect on our business, financial condition, results of operations and cash flows, and you should carefully consider them.  It is not possible to predict or identify all such factors.  For a discussion of potential risks or uncertainties affecting us, please refer to the information under the heading “Item 1A—Risk Factors” in our 2024 Annual Report. Additional risks and uncertainties that are not yet identified or that we currently believe to be immaterial may also materially harm our business, financial condition, results of operations and cash flows.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 

Issuer Purchases of Equity Securities: 

(In millions, except number of shares and per share amounts)Period in 2025TotalNumber ofShares PurchasedAverage PricePaid Per ShareTotal Number of SharesPurchased as Part ofPublicly AnnouncedPrograms (1)ApproximateDollar Value ofShares thatMay Yet bePurchasedUnder thePrograms (1)January 1 - January 3191,518 $210.08 91,518 $355.3 February 1 - February 2858,295 209.26 58,295 343.1 March 1 - March 31149,133 208.19 149,133 312.1 Total298,946 $208.98 298,946 $312.1 

(1)Shares repurchased pursuant to the November 2023 publicly announced share repurchase authorization of up to $600.0 million aggregate cost at purchase of outstanding common stock. As of March 31, 2025, $312.1 million aggregate cost at purchase remained unused under the repurchase authorization. 

Item 5. Other Information

Rule 10b5-1 and non-Rule 10b5-1 Trading Arrangements

On March 10, 2025, Keith W. Demmings, our President and Chief Executive Officer, and a director on our Board, adopted a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “Plan”).  Mr. Demmings’s Plan provides for the sale of up to 18,000 shares of our common stock, and terminates on the earlier of: (i) February 27